First experience with a new nonthoracotomy defibrillation lead system

American Heart Journal

Volumn 132, Issue 3, 1996, Pages 599-607

  Trappe, Hans Joachim ^a   Pfitzner, Petra ^b   Wenzlaff, Paul ^b   Fain, Eric ^b   Fieguth, Hans Gerd ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; SAFETY; THORACOTOMY; WAVEFORM;

EID: 0029860273     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90244-6     Document Type: Article

References (40)

1. Bardy GH, Troutman C, Poole JE, Kudenchuk PJ, Dolack GL, Johnson G, et al. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation 1992;85:1689-98.
2. Rabinovich R, Muratone C, Iglesias R, Gonzalez M, Serafrica M, Liprandi AS. Results of delivered therapy for ventricular tachycardia or ventricular fibrillation in patients with third-generation implantable cardioverter-defibrillators. PACE 1995;18:133-6.
3. Trappe HJ, Klein H. Clinical results of cardioverter defibrillator therapy. In: Singer I, editor. Implantable cardioverter defibrillators. Mount Kisco, N.Y.: Futura Publishing Company, 1994;487-505.
4. Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, et al. Implantable transvenous cardioverter-defibrillators. Circulation 1993;87:1152-68.
5. Yee R, Klein GJ, Leitch JW, Guiraudon GM, Guiraudon CM, Jones DL, et al. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator: nonthoracotomy approach to implantation. Circulation 1992;85:196-204.
6. Luceri RM, Zilo P, Habal SM, David IB. Cost and length of hospital stay: comparisons between nonthoracotomy and epicardial techniques in patients receiving implantable cardioverter defibrillators. PACE 1995; 18:168-71.
7. Trappe HJ, Klein H, Fieguth HG, Kielblock B, WenzlaffP, Lichtlen PR. Initial experience with a new transvenous defibrillation system. PACE 1993;16:134-40.
8. Kelly PA, Mann DE, Harken AH, Manart FD, Reiter MJ. Implantation of an automatic defibrillator using a new nonthoracotomy approach. PACE 1994;17:2247-54.
9. Trappe HJ, Pfitzner P, Fieguth HG, Wenzlaff P, Kielblock B, Klein H. Nonpharmacological therapy of ventricular tachyarrhythmias: observations in 554 patients. PACE 1994;17:2172-7.
10. Winkle RA. The implantable defibrillator: progression from first to third generation devices. In: Zipes DP, Jaliffe J, editors. Cardiac electrophysiology: from cell to bedside. Philadelphia: WB Saunders Company, 1990:963-9.
11. Klein LS, Miles WM, Zipes DP. Antitachycardia devices: realities and promises. J Am Coll Cardiol 1991;18:1349-62.
12. Trappe HJ, Pfitzner P, Heintze J, Kielblock B, Wenzlaff P, Fieguth HG, et al. Cardioverter-defibrillator implantation in the cath-lab: experience in 48 patients. Am Heart J 1995;129:259-64.
13. Trappe HJ, Klein H, Kielblock B. Role of antitachycardia pacing in patients with third generation cardioverter defibrillators. PACE 1994; 17:506-13.
14. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons, 1966:104.
15. Brachmann J, Schmitt C, Beyer T, Waldecker B, Offner B, Schöls W, et al. Early experience with third generation cardioverter defibrillators. In: Saksena S, Lüderitz B, editors. Interventional electrophysiology. Mount Kisco, N.Y.: Futura Publishing Company, 1991:447-531.
16. Saksena S, Mehta D, Krol RB, Tullo NG, Saxena A, Kaushik R, et al. Experience with a third-generation implantable cardioverter defibrillator. Am J Cardiol 1991;67:1375-84.
17. Hurwitz JL, Hook BG, Flores BT, Marchlinski FE. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 1993;21:895-900.
18. Trappe HJ, Fieguth HG, Pfitzner P, Heintze J, Wenzlaff P, Kielblock B. Epicardial and nonthoraeotomy defibrillation lead systems combined with a cardioverter defibrillator. PACE 1995;18:127-32.
19. Saksena S and the PCD Investigators and Participating Institutions. PACE 1993;16:202-7.
20. Saksena S, Parsonnet V. Implantation of a cardioverter/defibrillator without thoracotomy using a triple electrode system. JAMA 1988; 259:69-72.
21. McGowan R, Maloney J, Wikoff B, Simmons T, Khoury D, McAlister H, et al. Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. J Am Coll Cardiol 1991;17:415-21.
22. Winkle RA, Mead RH, Ruder MA, Gaudiani V, Buch WS, Pless B, et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 1989;117:122-7.
23. Blanchard SM, Knisley SB, Walcott GP, Ideker RE. Defibrillation waveforms. In: Singer I, editor. Implantable cardioverter defibrillator. Mount Kisco, N.Y.: Futura Publishing Company, 1994:153-78.
24. Venditti FJ, Martin DT, Vassolas G, Bowen S. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation 1994;89:216-23.
25. Bardy GH, Buono G, Troutman CL, Hayes JJ, Kudenchuk PJ, Dolack GL, et al. Subacute changes in defibrillation threshold following multiprogrammable defibrillator implantation in man [abstract]. J Am Coll Cardiol 1991;17:344A.
26. Bardy G, Johnson GJ, Poole JE, Dolack GL, Kudenchuk PJ, Kelso D, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-7.
27. Levy S, Ricard P, Dolla E. Clinical results with nonthoracotomy lead systems and implications for implantable cardioverter-defibrillator practice: the European experience. In: Singer I, editor. Implantable cardioverter defibrillator. Mount Kisco, N.Y.: Futura Publishing Company, 199:507-14.
28. Kelly PA, Cannom DS, Garan H, Mirabal GS, Harthorne JW, Hurvitz RJ, et al. The automatic implantable cardioverter defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988;11:1278-86.
29. Fahy GJ, Kleman JM, Wilkoff BL, Morant VA, Pinski SL. Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems. PACE 1995;18: 172-8.
30. Grimm W, Flores BT, Marchlinski FE. Complications of implantable cardioverter defibrillator therapy: follow-up of 241 patients. PACE 1993;16:218-22.
31. Böcker D, Block M, Hammel D, Isbruch F, Brunn J, Bansch D. Re-operations after implantation of automatic defibrillators with endocardial leads; long-term results in 348 patients [abstract]. Eur Heart J 1995; 16:262.
32. Korte T, Jung W, Hügl B, Spehl S, Wolpert C, Schumacher B, et al. Complications and mortality after implantation of transvenous defibrillation systems [abstract]. Eur Heart J 1995;16:196.
33. Halperin BD, Kron J, Ott GY, Oliver R, McAnulty J. Lead failures in a nonthoracotomy defibrillation lead system [abstract]. Circulation 1995;92:I-151.
34. Deering TF, Kocheri AG, Fitts S, Walker A, Vaccari M, Vergassola R. Worldwide experience with the GUARDIAN ATP II 4211 ICD system [abstract]. PACE Electrophysiol 1995;18:944.
35. Newby K, Moredock L, Rembert J, Wharton JM, Sorrentino R, Greenfield RA, et al. Impact of the defibrillating surface area of an additional superior vena cava electrode on the unipolar right ventricular coil/ defibrillator can system [abstract]. J Am Coll Cardiol 1995;407A.
36. Martin DT, John R, Venditti FJ Jr. Increase in defibrillation threshold in nonthoracotomy implantable defibrillators using a biphasic waveform. Am J Cardiol 1995;76:263-6.
37. Lang DJ, Heil JE, Hahn SJ, Lindstrom CC, Derfus DL. Implantable cardioverter defibrillator lead technology: improved performance and lower defibrillation thresholds. PACE 1995;18:548-59.
38. Prystowsky EN. Future expectations of implantable cardioverter defibrillator therapy. PACE 1995;18:609-15.
39. Touboul P. Atrial defibrillator: is it needed? Would society pay for it? PACE 1995;18:616-21.
40. Nappholz T. Dual chamber defibrillator: from theoretical concepts to implementation. In: Singer I, editor. Implantable cardioverter defibrillators. Armonk, N.Y.: Futura Publishing Company, 1994:711-30.